The products are readily accessible throughout Ireland, the UK and Europe
AstroZhi, a pioneer in scientific research-backed dietary supplements, has announced a groundbreaking development in healthcare with the introduction of specialised products aimed at aiding in the recovery from long-COVID syndrome. This long-anticipated move positions AstroZhi at the forefront of innovation in the field of health and wellness.
AstroZhi’s dedication to advancing the frontiers of healthcare has culminated in the launch of these cutting-edge supplements, which are poised to revolutionise the landscape of post-COVID health management. The range also includes products designed to support anxiety, aid sleep and detox from unwanted parasites.
Commenting on the news, Vincent Nolan, Managing Director of AstroZhi, said: “The global health crisis brought on by the COVID-19 pandemic has underscored the critical need for effective, unbiased solutions to combat the lingering effects of the virus and its associated vaccinations. Recent studies have shown what many had suspected; that the COVID Spike protein is persisting in the body post-SARS-CoV-2 infection and vaccination, that it is highly toxic, long-lasting, and a major driver of long-COVID syndrome and its associated immune issues which are now commonly presenting. Our team has diligently monitored this research, incorporating powerful compounds like Nattokinase, Bromelain, and Curcumin. These ingredients, identified by top medical experts as essential in counteracting the effects of the spike protein, are integral to our formulas. We are delighted to announce the launch of our products, which are now readily accessible throughout Ireland, the UK, and Europe. This marks the beginning of a journey towards enhanced well-being and recovery for individuals everywhere.”
